Computational studies on the histone deacetylases and the design of selective histone deacetylase inhibitors

Difei Wang1

  • 1Laboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. wangdi@mail.nih.gov

Insights

Histone deacetylase (HDAC) inhibitors show promise for cancer treatment. Computational studies, particularly molecular modeling, are crucial for developing more effective and selective HDAC inhibitors against cancer-related enzymes.

Area of Science:

  • Biochemistry and Molecular Biology
  • Medicinal Chemistry
  • Computational Biology

Background:

  • Histone deacetylase (HDAC) enzymes play a critical role in cancer pathogenesis and other diseases.
  • HDAC inhibitors represent a promising therapeutic strategy for various cancers.
  • Understanding HDAC enzyme function is key to developing targeted cancer therapies.

Purpose of the Study:

  • To review the role of computational studies in understanding HDAC enzymes.
  • To highlight the importance of molecular modeling in developing novel HDAC inhibitors.
  • To summarize computational approaches for targeting different HDAC sub-classes.

Main Methods:

  • Review of existing literature on computational studies of HDAC enzymes.
  • Emphasis on structure-based and ligand-based computational approaches.
  • Analysis of molecular modeling techniques for inhibitor design.

Main Results:

  • Computational studies provide valuable insights into HDAC enzyme mechanisms.
  • Molecular modeling aids in designing HDAC inhibitors with enhanced efficacy and selectivity.
  • Structure-based and ligand-based methods are effective for targeting diverse HDAC sub-classes.

Conclusions:

  • Computational approaches are indispensable tools in HDAC inhibitor drug discovery.
  • Molecular modeling significantly contributes to the development of targeted cancer therapeutics.
  • Further research utilizing computational methods will advance the treatment of HDAC-related diseases.

Related Concept Videos

Spreading of Chromatin Modifications02:25

Spreading of Chromatin Modifications

The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer is an enzyme that can...
Histone Modification02:32

Histone Modification

The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone deacetylase,...
Histone Modification02:32

Histone Modification

The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone deacetylase,...
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Histone Variants at the Centromere02:30

Histone Variants at the Centromere

Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3 variants are also...
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.